Health and Fitness Health and Fitness
Wed, October 10, 2012
[ Wed, Oct 10th 2012 ] - Market Wire
MethylGene Provides Clinical Update on its MGCD290 Novel Antifungal Therapeutic Program
[ Wed, Oct 10th 2012 ] - Market Wire
First Patient Enrolled in REPRISE II TAVR Clinica .. afety and Performance of the Lotusa" Valve System
Tue, October 9, 2012
[ Tue, Oct 09th 2012 ] - Market Wire
Paladin Announces Agreement With QRxPharma for Novel Acute Pain Product
[ Tue, Oct 09th 2012 ] - Market Wire
Quidel to Hold Third Quarter 2012 Financial Results Conference Call on October 23, 2012
[ Tue, Oct 09th 2012 ] - Market Wire
Depomed, Inc. Appoints Dr. Samuel Saks To Its Board Of Directors
[ Tue, Oct 09th 2012 ] - Market Wire
PDL BioPharma Completes Royalty Transaction with AxoGen
[ Tue, Oct 09th 2012 ] - Market Wire
Amerigroup Announces Conference Participation for October
[ Tue, Oct 09th 2012 ] - Market Wire
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Orapred ODT
[ Tue, Oct 09th 2012 ] - Market Wire
Manhattan Isotope Technology Receives Drug Master File Acknowledgment Letter From FDA
[ Tue, Oct 09th 2012 ] - Market Wire
Extendicare Announces 2012 Third Quarter Financia .. ults News Release and Conference Call Information
[ Tue, Oct 09th 2012 ] - Market Wire
Interim Analysis Supports Continuation of Can-Fite's Phase 2/3 Psoriasis Clinical Study with CF101
[ Tue, Oct 09th 2012 ] - Market Wire
Cynosure To Host Third-Quarter 2012 Financial Results Conference Call On October 23
[ Tue, Oct 09th 2012 ] - Market Wire
Aethlon Medical to Present at the RedChip 15th Annual Small-Cap Conference on October 11th
[ Tue, Oct 09th 2012 ] - Market Wire
Critical Outcome Technologies Inc. Achieves Important Milestone for AML Program
[ Tue, Oct 09th 2012 ] - Market Wire
Boston Scientific Launches Victory Guidewire For Crossing Resistant Lesions In Peripheral Arteries
[ Tue, Oct 09th 2012 ] - Market Wire
Immunovaccine Reports Positive Interim Results fr .. of Ovarian Cancer Vaccine Candidate, DPX-Survivac
[ Tue, Oct 09th 2012 ] - Market Wire
Matrixx Initiatives Revises All-cash Acquisition Offer For ProPhase Labs
Mon, October 8, 2012
[ Mon, Oct 08th 2012 ] - Market Wire
Rusch®; EZ-Blocker™ Endobronchial Blocker Receives 510(k) Clearance
[ Mon, Oct 08th 2012 ] - Market Wire
Boston Scientific to Acquire Rhythmia Medical, Inc.
[ Mon, Oct 08th 2012 ] - Market Wire
Elan Announces Results Through Consent Payment De .. nd Consent Solicitation for 8.75% Senior Notes Du
[ Mon, Oct 08th 2012 ] - Market Wire
Luminex Corporation Third Quarter Earnings Release Scheduled for October 29, 2012
[ Mon, Oct 08th 2012 ] - Market Wire
Edwards Lifesciences Announces Preliminary Third Quarter 2012 Sales
[ Mon, Oct 08th 2012 ] - Market Wire
Humana Names Vice President and Medical Officer for Florida Commercial Markets
[ Mon, Oct 08th 2012 ] - Market Wire
Aetna Awards $100,000 to Winners of the CarePass& .. r Developer Challenge; Announces Seven New Ca
[ Mon, Oct 08th 2012 ] - Market Wire
Cigna HealthCare of Arizona Honors Breast Cancer .. he Arizona Cardinals Breast Cancer Awareness Game
[ Mon, Oct 08th 2012 ] - Market Wire
Grifols Announces First Patient Enrolled and Dose .. al of Alpha-1 HC Aerosol to Treat Cystic Fibrosis
[ Mon, Oct 08th 2012 ] - Market Wire
WellPoint Affiliates Expand Medicare Advantage Plans to 46 New Counties in 2013
[ Mon, Oct 08th 2012 ] - Market Wire
Humana Inc. to Release Third Quarter 2012 Results .. st Biennial Investor Meeting on November 13, 2012
[ Mon, Oct 08th 2012 ] - Market Wire
New Telit GPS Miniature Receiver Based on Latest 3-D Embedded Technology is Market's Smallest
[ Mon, Oct 08th 2012 ] - Market Wire
30 P.M. Eastern to Discuss G4™ PLATINUM Approval

30 P.M. Eastern to Discuss G4™ PLATINUM Approval


Published on 2012-10-08 07:00:54 - Market Wire
  Print publication without navigation


SAN DIEGO--([ ])--DexCom, Inc. (NASDAQ:DXCM) today announced that Terry Gregg, CEO, and Kevin Sayer, President, will hold a conference call to discuss FDAas approval of the companyas G4 PLATINUM continuous glucose monitoring system starting at 4:30 p.m. (Eastern Time) on Monday, October 8, 2012. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at [ www.dexcom.com ] under the investor relations, events and webcast section, and will be archived for future reference.

To listen to the conference call, please dial 1 (888) 771-4371 (US/Canada) or 1 (847) 585-4405 (International) and use the confirmation number "33515973" approximately five minutes prior to the start time.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients with diabetes and by healthcare providers in the hospital.

Contributing Sources